Clinical outcomes and nephrotoxicity of colistin loading dose for treatment of extensively drug-resistant Acinetobacter baumannii in cancer patients

BACKGROUND: Colistin is a last-line defense therapy against extensively drug-resistant Acinetobacter baumannii (XDR-AB). Despite a loading dose of colistin being applied in many clinical practices, studies evaluating the effect of the loading dose of colistin in cancer patients remain limited. PATIE...

Descripción completa

Detalles Bibliográficos
Autores principales: Katip, Wasan, Uitrakul, Suriyon, Oberdorfer, Peninnah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593398/
https://www.ncbi.nlm.nih.gov/pubmed/28919792
http://dx.doi.org/10.2147/IDR.S144314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593398/
https://www.ncbi.nlm.nih.gov/pubmed/28919792
http://dx.doi.org/10.2147/IDR.S144314

Ejemplares similares